Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Light Up Total Solution Public Company Limited (LTS.BK) operates within the home improvement sector in Thailand, focusing on providing lighting solutions and related products. The company's competitive position is bolstered by its extensive distribution network across major urban centers and a growing portfolio of energy-efficient lighting products.
LTS.BK generates revenue primarily through the sale of lighting products, including LED and smart lighting solutions, which are increasingly in demand due to energy efficiency trends. The company benefits from a strong brand reputation and established relationships with suppliers, allowing for competitive pricing and product differentiation.
Consumer spending trends in home improvement
Regulatory changes promoting energy-efficient products
Market share gains against competitors
Fluctuations in raw material costs impacting gross margins
Technological disruption from new lighting technologies
Regulatory changes affecting product standards
Intensifying competition from local and international home improvement retailers
Potential market entry of low-cost competitors
Negative net income leading to potential liquidity concerns
Low operating cash flow impacting operational flexibility
high - The company's performance is closely tied to consumer spending, which is influenced by GDP growth and overall economic conditions.
Higher interest rates can dampen consumer spending on home improvement projects, negatively impacting demand for LTS.BK's products.
minimal - The company's low debt-to-equity ratio indicates limited reliance on credit, reducing vulnerability to tightening credit conditions.
growth - Investors may be attracted by the company's high revenue growth rate despite current losses.
high - The stock has exhibited significant price volatility, evidenced by a 47.9% decline over the past year.
